Solvay SA

  • Market Cap: N/A
  • Industry: Specialty Chemicals
  • ISIN: BE0003470755
EUR
27.60
-59.01 (-68.13%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Solvay SA stock-summary
stock-summary
Solvay SA
Specialty Chemicals
Solvay SA is a Belgium-based international chemical and advanced materials company. Through its subsidiaries, it operates four segments: Advanced Materials, Advanced Formulations, Performance Chemicals and Corporate & Business Services. Advanced Materials offers high-performance materials for multiple applications primarily in the automotive, aerospace, electronics, and health markets providing sustainable mobility solutions, reducing weight and improving CO2 and energy efficiency. Advanced Formulations serves primarily the consumer goods, agro and food, and energy markets offering customized specialty formulations that impact surface chemistry and alter liquid behavior while minimizing the environmental impact. Performance Chemicals specializes in chemical intermediates serving mainly the consumer goods and food markets. Corporate & Business Services includes corporate and other business services, such as the research and innovation center, and energy services.
Company Coordinates stock-summary
Company Details
Rue de Ransbeek 310 , BRUXELLES None : 1120
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 4 Foreign Institutions (0.19%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Nicolas Boel
Chairman of the Board
Dr. Ilham Kadri
Chairman of the Management Board, Chief Executive Officer, Director
Mr. Charles Casimir-Lambert
Director
Mr. Bernard de Laguiche
Director
Mr. Herve Coppens d'Eeckenbrugge
Independent Director
Mrs. Francoise de Viron
Independent Director
Mrs. Evelyn Diego du Monceau de Bergendal
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
1,212 Million
(Quarterly Results - Jun 2025)
Net Profit:
11 Million
stock-summary
Industry

Specialty Chemicals

stock-summary
Market cap

EUR 2,967 Million ()

stock-summary
P/E

9.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.32

stock-summary
Return on Equity

30.45%

stock-summary
Price to Book

2.47